June 15, 2023
Breakthrough T1D Real Estate Games Raise Critical Funds for Type 1 Diabetes Research
June 15, 2023
Zucara Therapeutics Announces Additional Funding from Breakthrough T1D to Support ZT-01 Phase 2 Study
June 14, 2023
QuLab Medical Receives Award from Breakthrough T1D to Advance Development of Minimally Invasive Dual Continual Glucose and Ketone Monitoring Patch for T1D
June 13, 2023
Integrated Medical Sensors Announces Award from Breakthrough T1D to Advance Development of a Continuous Glucose+Ketone Monitoring Platform
June 1, 2023
Breakthrough T1D Real Estate Games Raise Critical Funds for Type 1 Diabetes Research
May 23, 2023
Minutia receives award from Breakthrough T1D to further develop real-time monitoring platform for cell therapies
May 22, 2023
Statement from Breakthrough T1D on the U.S. Food and Drug Administration (FDA) clearance of the iLet® Insulin-Only Bionic Pancreas:
May 18, 2023
JDRF’s 2023 TypeOneNation Summit Series Explores the Intersection of Mental Health and Type 1 Diabetes: “Tell Me How You Really Feel – Balancing Mental Health and T1D”
May 18, 2023
Breakthrough T1D Encourages Everyone Living with Diabetes to be Proactive about Eye Health in Recognition of Healthy Vision Month
May 5, 2023
Congratulations to Jeffrey Bluestone, Ph.D., for Election to the National Academy of Sciences
